Current Report Filing (8-k)
02 February 2017 - 11:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 2, 2017
Commission File Number:
0-24260
Amedisys, Inc.
(Exact name of registrant as specified in charter)
|
|
|
Delaware
|
|
11-3131700
|
(State or other jurisdiction
|
|
(IRS Employer
|
of incorporation)
|
|
Identification No.)
|
3854 American Way, Suite A, Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225)
292-2031
or (800)
467-2662
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (
see
General Instruction A.2 below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 7.01.
|
Regulation FD Disclosure.
|
On February 2, 2017, Amedisys, Inc. (the
Company) issued a press release announcing that its subsidiary, Associated Home Care, has closed on its acquisition of Home Staff, LLC, a personal care provider, headquartered in Worcester, Massachusetts, a copy of which is furnished
herewith as Exhibit 99.1 to this Current Report on Form
8-K.
The information included in this
Current Report on Form
8-K
under this Item 7.01 (including Exhibit 99.1 hereto) is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of Section 18, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information included in this Current Report on Form
8-K
under this Item 7.01 (including Exhibit 99.1 hereto) will
not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated February 2, 2017
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
AMEDISYS, INC.
|
|
|
By:
|
|
/s/ Paul B. Kusserow
|
|
|
Paul B. Kusserow
President and Chief
Executive Officer
|
|
DATE: February 2, 2017
|
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated February 2, 2017
|
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2024 to May 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From May 2023 to May 2024